Immunohistochemistry: best clinics abroad

Immunohistochemistry is a laboratory examination of tissue using antibodies to detect selected proteins in cells. A pathologist assesses the staining alongside the tissue's usual microscopic appearance and clinical information. It can help clarify a tumour's type, possible origin or particular features relevant to treatment decisions. It does not measure overall immune health or independently determine a cancer's stage. The marker panel should answer a specific diagnostic question; one positive stain does not explain the whole diagnosis.

Testing abroad may be considered for a difficult case, specialist diagnostic review or assessment of a selected marker in an appropriate laboratory. Material from an earlier biopsy or operation may be suitable, so another procedure is not always necessary. Before travelling, share the pathology report and ask whether blocks and slides can be submitted for expert review. Confirm material requirements, the proposed tests, timing and costs. Arrange an explanation of the final findings with your treating clinician, rather than relying on a list of stains alone.

What the examination can clarify

Immunohistochemistry complements routine microscopic examination of tissue. It may distinguish similar tumours, clarify where cells originated or assess particular features relevant to possible treatment. A pathologist selects markers for the suspected diagnosis. A broad panel is not necessary for everyone: usefulness depends on the clinical question and previous investigations within oncology care.

Material and preparation

The laboratory usually needs paraffin-embedded tissue blocks or appropriately prepared unstained slides. Provide the original pathology report, previous staining results and information about the sample's site and collection date. Confirm the required documents and material, as laboratory requirements differ. Glass slides are fragile; arrange packaging and delivery with the receiving service.

Specialists assess tissue quantity, preservation, processing and suitability for the selected tests. Insufficient material may lead to a request for further blocks or discussion of another biopsy. The clinical team decides whether a new procedure is needed. Testing an existing specimen does not require patient fasting; preparation and risks of any new sampling depend on that procedure.

How the analysis is performed

Thin tissue sections are treated with selected antibodies. A staining system makes protein distribution visible under a microscope. Reliable assessment depends on sample quality, a validated method and staining controls. The pathologist considers the signal's location and intensity alongside the tissue's appearance.

Some findings require additional tests. For example, selected HER2 results may need a method that examines the gene. Protein staining and gene analysis answer different questions. Further testing should follow the clinical indication rather than being an automatic requirement for every patient.

Timing, reporting and costs

Technical staining and a complete diagnostic review have different timelines. Staining may take several working days; complex interpretation can take longer when further tests or material are needed. Confirm when the reporting period starts after sample receipt and how results will be discussed. Ask about remote review before booking travel.

The report should relate findings to the diagnosis and explain limitations. A marker does not guarantee treatment response, and staging requires other clinical information. Costs depend on marker numbers, material preparation, additional tests and specialist interpretation. Check charges for delivery, consultations and report copies.

Frequently asked questions

Is another biopsy necessary?

Not always. Suitable blocks or slides from an earlier examination may be sufficient; the laboratory assesses adequacy.

Does this test assess immunity?

No. It identifies selected proteins in tissue and does not replace an immune-system assessment.

Does a positive marker always mean cancer?

No. Its meaning depends on the marker, the cells and the overall microscopic findings. A pathologist explains the result.